SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-212770
Filing Date
2017-06-26
Accepted
2017-06-26 12:36:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d416229dsc13da.htm SC 13D/A 72219
2 EX-99.A d416229dex99a.htm EX-99.A 71493
3 EX-99.B d416229dex99b.htm EX-99.B 14561
4 EX-99.C d416229dex99c.htm EX-99.C 10645
5 GRAPHIC g416229dsp027.jpg GRAPHIC 3198
6 GRAPHIC g416229dsp027a.jpg GRAPHIC 3085
7 GRAPHIC g416229dsp037.jpg GRAPHIC 2371
  Complete submission text file 0001193125-17-212770.txt   182795
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89517 | Film No.: 17929269
SIC: 2834 Pharmaceutical Preparations

Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A